Statistics for Novartis AG (id:12977 NOVN)
Valuation metrics
Market cap
173.38B
Enterprise value
171.83B
Trailing P/E (ttm)
16.94
Forward P/E
14.03
PEG ratio
14.03
Price/Sales (ttm)
3.47
Price/Book (mrq)
4.00
Enterprise Value/Revenue
3.85
Enterprise Value/EBITDA
9.17
Overview
Shares outstanding
2.00B
Float
1.91B
Shares short
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
4.16M
Average volume (90 days)
Price summary
52-Week low
83.63
52-Week high
102.72
52-Week change
3.97%
Beta
3.00
50-Day moving average
93.62
200-Day moving average
94.02
Dividends and splits
Forward annual dividend rate
13.20
Forward annual dividend yield
3.00
Trailing annual dividend rate
3.92%
Trailing annual dividend yield
5.00
5-Year annual dividend yield
3.67
Payout ratio
3.00
Dividend date
March 11, 2024
Ex-dividend date
March 7, 2024
Last split factor
2:1
Last split date
October 4, 2023
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
35.25%
Operating margin
33.47%
Operational effectiveness
Return on assets
10.59%
Return on equity
28.79%
Income statement
Revenue (ttm)
24.54
Revenue per share (ttm)
24.54
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
34.19B
EBITDA
19.71B
Net income to common (ttm)
10.50B
Diluted EPS (ttm)
5.12
Quarterly earnings growth (yoy)
81.10%
Balance sheet
Total cash (mrq)
12.37B
Total cash per share (mrq)
6.93
Total debt (mrq)
28.71B
Total Debt/Equity (mrq)
74.03
Current ratio (mrq)
111.10%
Book value per share (mrq)
21.67
Cash flow
Cash flow statement
14.26B
Levered free cash flow (LFCF)
5.07B